In8bio

Provider of immune based therapies for the treatment of cancer

placeNew York City, New York, United States calendar_todayFounded 2020 groups31 employees language in8bio.com

Registered entities

Innovation

7 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 53 times.

YearFilings
20191
20201
20212
20222
20233
20242
20256
20264

Social engagement

Social engagement: 4.9K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Accelerator & incubator150%

Recent activity

24 Jun 2026
Event
Biotech webinar hosted by Webull Financial
10 Jun 2026
Event
Bio International Convention
3 Jun 2026
Event
Nobel Emerging Growth Virtual Equity Conference
Coming soon